ALK and B-cell non-Hodgkin lymphoma: We focused here for the first time on allelic imbalance of tumours with ALK fusion with a novel technique which has already shown the involvement of loss of A20 function in the pathogenesis of a subset of B-cell lymphomas[33] and gain of function of C-CBL tumour suppressor in myeloid neoplasms[34].